MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2022 International Congress

    Case report: Parkinsonim with dyskinesia secondary to amyloid angiopathy

    K. Khelfaoui Tredano, G. Berrada, Y. Hsaini, A. Benomar, H. Tibar (Rabat, Morocco)

    Objective: To report a case of parkinsonism secondary to amyloid angiopathy and discuss the pathophysiology and treatment of this entity. Background: Cerebral amyloid angiopathy is…
  • 2022 International Congress

    Burden of COVID-19 among patients with Parkinson’s disease and associated clinical outcomes: Evidence from a meta-analysis

    S. Hussain (Brno, Czech Republic)

    Objective: To understand the burden of covid-19 among patients with Parkinson’s disease and associated clinical outcomes. Background: COVID-19 has affected millions of patients around the…
  • 2022 International Congress

    Capturing the complexity of patients with parkinsonism: Baseline characteristics of participants in the PRIME-UK cross-sectional study

    E. Tenison, D. Pendry-Brazier, M. Smith, F. Lithander, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

    Objective: This cross-sectional study seeks to describe the symptomatology and health needs of a representative sample of people with parkinsonism, including those living with frailty,…
  • 2022 International Congress

    CSF biomarkers in neurodegenerative parkinsonism can distinguish between multiple system atrophy and 4-repeat tauopathies, but not between disease with Lewy bodies and multiple system atrophy

    P. Kanovsky, K. Bucilova, M. Chudackova, D. Konickova, K. Pekarova, K. Sklenarova, M. Kaiserova, S. Kurcova, M. Nevrly, J. Zapletalova, M. Strnad, K. Mensikova (Olomouc, Czech Republic)

    Objective: To assess the usefulness of a defined set of blood-based and cerebrospinal fluid-based biomarkers in the differential diagnosis of neurodegenerative proteinopathies. Background: The diagnostic…
  • 2022 International Congress

    Clinical presentation of SNCA Duplication Parkinsonism in a Family Kindred

    K. Dent, M. Rochman, D. Kremens, J. Ratliff (Philadelphia, USA)

    Objective: To report phenotype variability in a family with SNCA duplication associated Parkinsonism. Background: Pathogenic variants in SNCA, the gene coding for α-synuclein, cause familial…
  • 2022 International Congress

    Characteristics and Techniques to Improve Micrographia in Parkinson’s Disease

    S. Shahid (Southampton, USA)

    Objective: To analyze and identify the characteristics found in micrographia and provide methods of improving the symptom. Background: Micrographia, also known as small handwriting, is…
  • 2022 International Congress

    Prevalence of GBA parkinsonism in Slovak Parkinson’s disease population

    A. Lacková, V. Han, P. Pavelekova, Z. Gdovinova, M. Skorvanek, K. Kulcsarova, M. Ostrozovicova, T. Lorincova, P. Bauer, CH. Beetz, S. Oppermann, E. Tusay, B. Kovacova, B. Stasko, E. Petro, S. Bohacova (Košice, Slovakia)

    Objective: Our study aimed to determine the prevalence of GBA parkinsonism in the Slovak population with Parkinson's disease (PD). Background: In recent years, there has…
  • 2022 International Congress

    Effects of gait symmetry manipulation on cortico-subthalamic interhemispheric coupling in parkinsonian patients by use of virtual reality

    J. Reuss, A. Gulberti, M. Knorr, M. Sengelmann, T. Schneider, M. Schaper, W. Hamel, A. Engel, C. Gerloff, C. Moll, M. Pötter-Nerger (Hamburg, Germany)

    Objective: The aim of this study is 1) to characterize gait-related neuronal oscillations and functional connectivity changes between cortico-subthalamic network nodes in Parkinson´s disease (PD)…
  • 2022 International Congress

    NPC1 is not a PD risk factor gene

    G. Barrel, M. Olmedillas, K. Kandaswamy, A. Westenberger, G. Hartmann, C. Klein, P. Bauer, C. Beetz (Rostock, Germany)

    Objective: To test the hypothesis of NPC1 to be a PD risk factor gene. Background: The many etiologies of PD include genetic risk factors. The…
  • 2022 International Congress

    CCDC88C p.R464H likely cause a novel late-onset parkinsonism phenotype

    Z. Lin, W. Luo (Hangzhou, China)

    Objective: We describe two sisters with late-onset parkinsonism associated with a CCDC88C variant (p.R464H). Background: Tsoi et al. (2014) identified a heterozygous missense mutation in the CCDC88C gene (R464H), by…
  • « Previous Page
  • 1
  • …
  • 50
  • 51
  • 52
  • 53
  • 54
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25111 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley